The relationship between gravidity and parity and colorectal cancer risk

Journal of Women's Health

Volumn 18, Issue 7, 2009, Pages 995-1001

  Wernli, Karen J ^a   Wang, Yinghui ^a   Zheng, Yingye ^a   Potter, John D ^a,b   Newcomb, Polly A ^a,b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDUCATIONAL STATUS; ENDOSCOPY; FEMALE; GRAVITY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; ORAL CONTRACEPTION; PARITY; PREGNANCY; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; RISK REDUCTION; SMOKING;

AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GRAVIDITY; HUMANS; MIDDLE AGED; PARITY; PREGNANCY; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RISK; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 70349199604     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1068     Document Type: Article

References (34)

1. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. J Natl Cancer Inst 1980;65:1201-1217.
2. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States. Cancer Causes Control 1997;8:146-158.
3. Tamakoshi K, Wakai K, Kojima M, et al. A prospective study of reproductive and menstrual factors and colon cancer risk in Japanese women: Findings from the JACC study. Cancer Sci 2004;95:602-607. (Pubitemid 39089643)
4. Talamini R, Franceschi S, Dal Maso L, et al. The Influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 1998;34:1070-1076.
5. Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA. Oral contraceptive use, reproductive factors, and colorectal cancer risk: Findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 2005;14:1212-1218.
6. Broeders MJ, Lambe M, Baron JA, Leon DA. History of childbearing and colorectal cancer risk in women aged less than 60: An analysis of Swedish routine registry data 1960- 1984. Int J Cancer 1996;66:170-175.
7. Negri E, La Vecchia C, Parazzini F, et al. Reproductive and menstrual factors and risk of colorectal cancer. Cancer Res 1989;49:7158-7161. (Pubitemid 20016609)
8. Martinez ME, Grodstein F, Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997;6:1-5.
9. Yoo KY, Tajima K, Inoue M, et al. Reproductive factors related to the risk of colorectal cancer by subsite: A case-control analysis. Br J Cancer 1999;79:1901-1906.
10. Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee IM. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 2007;165:794-801.
11. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991;2:201-207.
12. Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF. Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 1997;8:75-79. (Pubitemid 27014225)
13. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1994;5:359-366.
14. Slattery ML, Mineau GP, Kerber RA. Reproductive factors and colon cancer: The influences of age, tumor site, and family history on risk (Utah, United States). Cancer Causes Control 1995;6:332-338.
15. Kvale G, Heuch I. Is the incidence of colorectal cancer related to reproduction? A prospective study of 63,000 women. Int J Cancer 1991;47:390-395.
16. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology, 2nd ed. Geneva: World Health Organization, 1990.
17. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of micro-satellite instability in colorectal cancer. Cancer Res 1998;58: 5248-5257.
18. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-1048.
19. Lindor NM, Smalley R, Barker M, et al. Ascending the learning curve-MSI testing experience of a six-laboratory consortium. Cancer Biomarkers 2006;2:5-9.
20. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by sub-site. Cancer Causes Control 1992;3:355-360.
21. Marcus PM, Newcomb PA, Young T, Storer BE. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995;5:303-309.
22. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap L, Wenstrom KD. Williams obstetrics, 22nd ed. New York: McGraw Hill, 2005.
23. Newcomb PA, Pocobelli G, Chia V. Why hormones protect against large bowel cancer: Old ideas, new evidence. Adv Exp Med Biol 2008;617:259-269.
24. Newcomb PA, Zheng Y, Chia VM, et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007;67:7534-7539.
25. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JR. Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 1987;316:229-234.
26. Patel DD, Bhatavdekar JM, Ghosh N, et al. Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator. Cancer 1994;73:570-574. (Pubitemid 24046595)
27. Wood AJ, Thomas CM, Baumforth KR, et al. Absence of prolactin gene expression in colorectal cancer. Mol Pathol 1999;52:135-139.
28. Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention, 3rd ed. Oxford: Oxford University Press, 2006.
29. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21:40-54.
30. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increases risk of microsatellite instability-positive colon cancer. Cancer Res 2001;61:126-130.
31. Surveillance, Epidemiology, and End Results (SEER) Program. Limited-use data (1973-2005). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at www.seer.cancer.gov
32. Bosetti C, Tavani A, Negri E, Trichopoulos D, La Vecchia C. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 2001;54:902-906.
33. Maskarinec G, Zhang Y, Takata Y, et al. Trends of breast cancer incidence and risk factor prevalence over 25 years. Breast Cancer Res Treat 2006;98:45-55.
34. White E. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health 1987;77:495-497.